ENOXAPARIN LEDRAXEN 2,000 IU (20 mg)/0.2 mL PRE-FILLED SYRINGE SOLUTION FOR INJECTION

Introduction

Package Leaflet: Information for the User

Enoxaparina Ledraxen 2,000 IU (20 mg)/0.2 ml Solution for Injection in Pre-filled Syringe

enoxaparina sodium

This medicine is subject to additional monitoring, which will allow for quick identification of new safety information. You can help by reporting any side effects you may get. The last section of this leaflet includes information on how to report side effects.

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

• Keep this leaflet, you may need to read it again.
• If you have any further questions, ask your doctor, pharmacist, or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

1. What is Enoxaparina Ledraxen and what is it used for
2. What you need to know before you use Enoxaparina Ledraxen
3. How to use Enoxaparina Ledraxen
4. Possible side effects
5. Storage of Enoxaparina Ledraxen

1. Contents of the pack and further information

1. What is Enoxaparina Ledraxen and what is it used for

Enoxaparina Ledraxen contains the active substance enoxaparin sodium, which is a low molecular weight heparin (LMWH).

Enoxaparina Ledraxen works in two ways.

1. Preventing existing blood clots from getting bigger. This helps your body to break them down and stop them from causing harm.
2. Stopping new blood clots from forming.

Enoxaparina Ledraxen can be used to:

• treat blood clots
• prevent blood clots from forming in the following situations:
• before and after surgery
• when you have a short-term illness and are unable to move for a period of time
• if you have had a blood clot due to cancer, to prevent more clots from forming.
• to prevent blood clots when you have unstable angina (a condition where not enough blood reaches the heart) or after a heart attack.
• prevent blood clots in the tubes of a dialysis machine (used in people with severe kidney problems).

2. What you need to know before you use Enoxaparina Ledraxen

N

• are allergic to:
• • enoxaparin sodium or any of the other ingredients of this medicine (listed in section 6)
  • heparin or other low molecular weight heparins such as nadroparin, tinzaparin, or dalteparin.

The signs of an allergic reaction include: rash, problems breathing or swallowing, swelling of the face, lips, tongue, mouth, throat, or eyes.

• have had a reaction to heparin that caused a severe decrease in the number of cells involved in blood clotting (platelets) in the last 100 days
• have antibodies against enoxaparin in your blood
• are bleeding heavily or have a high risk of bleeding, such as:
• stomach ulcer, recent brain or eye surgery, or cerebral hemorrhage.
• are using Enoxaparina Ledraxen to treat blood clots, and you are going to have:
• • a lumbar puncture or spinal puncture
  • surgery with spinal or epidural anesthesia.

A

Enoxaparina Ledraxen should not be exchanged with other medicines that belong to the group of low molecular weight heparins. This is because they are not exactly the same and do not have the same activity or instructions for use.

Consult your doctor or pharmacist before starting to use Enoxaparina Ledraxen if:

• you have ever had a reaction to heparin that caused a severe decrease in the number of cells involved in blood clotting (platelets)
• you have had a heart valve implanted
• you have endocarditis (an infection of the inner lining of the heart)
• you have a history of stomach ulcers
• you have recently had a stroke (cerebrovascular accident)
• you have high blood pressure
• you have diabetes or problems with the blood vessels in your eyes caused by diabetes (known as diabetic retinopathy)

retinopathy)

• you have recently had eye or brain surgery
• you are an elderly person (over 65 years old) and especially if you are over 75 years old
• you have kidney problems
• you have liver problems
• you have a very low or high weight
• you have high levels of potassium in your blood (which could be checked with a blood test)
• you are currently using medicines that affect bleeding (see below - Use of Enoxaparina Ledraxen with other medicines)
• you have any problems with your spine or have had spinal surgery.

If you are affected by any of these conditions (or are unsure), consult your doctor or pharmacist before using Enoxaparina Ledraxen.

This medicine contains less than 1 mmol (23 mg) of sodium per dose, which is essentially "sodium-free".

Tests and Checks

You may need to have a blood test before you start using this medicine, and while you are using it; this is to check the level of cells involved in blood clotting (platelets) and the levels of potassium in your blood.

Children and Adolescents

The efficacy and safety of Enoxaparina Ledraxen in children and adolescents have not been established.

Other Medicines and Enoxaparina Ledraxen

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

• Warfarin - used to reduce blood clotting
• Aspirin (also known as acetylsalicylic acid or AAS), clopidogrel, or other medicines used to prevent blood clots (see also section 3, "Change of anticoagulant treatment")
• Dextran injection - used as a blood substitute
• Ibuprofen, diclofenac, ketorolac, and other medicines known as non-steroidal anti-inflammatory drugs (NSAIDs) used to treat pain and inflammation in arthritis and other diseases
• Prednisolone, dexamethasone, and other medicines used to treat asthma, rheumatoid arthritis, and other diseases
• Medicines that increase the level of potassium in your blood, such as potassium salts, diuretics, and some medicines for heart problems

O

In case you are going to have a lumbar puncture or are going to undergo surgery where spinal or epidural anesthesia will be used, inform your doctor that you are using Enoxaparina Ledraxen.

E

If you are pregnant, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before using this medicine.

If you are pregnant and have a mechanical heart valve, you may have a higher risk of blood clots. Your doctor will discuss this with you.

If you are breast-feeding or plan to breast-feed, you should consult your doctor before using this medicine.

C

Enoxaparina Ledraxen does not affect the ability to drive and use machines.

It is recommended that the healthcare professional records the trade name and batch number of the product you are using.

3. How to use Enoxaparina Ledraxen

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.

U

• Normally, your doctor or nurse will give you Enoxaparina Ledraxen. This is because it needs to be given by injection.
• Enoxaparina Ledraxen is usually given by injection under the skin (subcutaneously).
• Enoxaparina Ledraxen can be given by injection into your veins (intravenously) after certain types of heart attacks and surgeries.
• Enoxaparina Ledraxen can be added to the tube that comes out of your body (arterial line) at the start of a dialysis session.

Sesión de diálisis.

• Do not give Enoxaparina Ledraxen into your muscle (intramuscularly).

Q

• Your doctor will decide the amount of Enoxaparina Ledraxen that you will be given. The amount will depend on the reason why it is being used.
• If you have kidney problems, you may be given a smaller amount of Enoxaparina Ledraxen.

1. Treatment of blood clots:
   • The usual dose is 150 IU (1.5 mg) per kilogram of body weight per day or 100 IU (1 mg) per kilogram of body weight twice a day.
   • Your doctor will decide how long you will receive Enoxaparina Ledraxen.

1. Prevention of blood clots during surgery or periods of limited mobility due to illness:
   • The dose will depend on the risk of you developing a clot. You will be given 2,000 IU (20 mg) or 4,000 IU (40 mg) of Enoxaparina Ledraxen per day.

If you are going to have surgery, you will usually be given the first injection 2 or 12 hours before the surgery.

• If you have limited mobility due to illness, you will usually be given 4,000 IU (40 mg) of Enoxaparina Ledraxen per day.

Your doctor will decide how long you will receive Enoxaparina Ledraxen.

1. Prevention of blood clots when you have unstable angina or after a heart attack:

Enoxaparina Ledraxen can be used in 2 different types of heart attacks. The amount of Enoxaparina Ledraxen that you will be given will depend on your age and the type of heart attack you have had.

Heart attack type IAMSEST (non-ST segment elevation myocardial infarction):

• The usual dose is 100 IU (1 mg) per kilogram of body weight every 12 hours.
• Usually, your doctor will tell you to also take aspirin (acetylsalicylic acid).
• Your doctor will decide how long you will receive Enoxaparina Ledraxen.

Heart attack type IAMCEST (ST segment elevation myocardial infarction) if you are under 75 years old:

• You will be given an initial intravenous injection of 3,000 IU (30 mg) of Enoxaparina Ledraxen.
• At the same time, you will be given an injection of Enoxaparina Ledraxen under the skin (subcutaneously). The usual dose is 100 IU (1 mg) per kilogram of body weight every 12 hours.
• Usually, your doctor will tell you to also take aspirin (acetylsalicylic acid).
• Your doctor will decide how long you will receive Enoxaparina Ledraxen.

Heart attack type IAMCEST if you are 75 years old or older:

• The usual dose is 75 IU (0.75 mg) per kilogram of body weight every 12 hours.
• The maximum amount of Enoxaparina Ledraxen given in the first two injections is 7,500 IU (75 mg).

Your doctor will decide how long you will receive Enoxaparina Ledraxen.

For patients undergoing percutaneous coronary intervention (PCI):

Depending on when you last received an injection of Enoxaparina Ledraxen, your doctor may decide to give you an additional dose of Enoxaparina Ledraxen before a PCI. This would be by injection into a vein.

1. Prevention of blood clots in the tubes of a dialysis machine
   • The usual dose is 100 IU (1 mg) per kilogram of body weight.
   • Enoxaparina Ledraxen is added to the tube that comes out of your body (arterial line) at the start of the dialysis session. This amount is usually enough for a 4-hour session. However, your doctor may give you another injection of 50 IU to 100 IU/kg (0.5 to 1 mg/kg) per kilogram of body weight if necessary.

If you are going to inject Enoxaparina Ledraxen yourself

If you can administer Enoxaparina Ledraxen yourself, your doctor or nurse will show you how to do it. Do not try to inject yourself if you have not been taught how to do it. If you are unsure, consult your doctor or nurse immediately. If the injection is given correctly under the skin (subcutaneously), this will help reduce pain and bruising at the injection site.

Before you inject Enoxaparina Ledraxen yourself

• Prepare what you will need: syringe, cotton swab with alcohol or soap and water, and a container for sharp objects
• Check the expiration date of the medicine. If it has expired, do not use it
• Check that the syringe is not damaged and that the solution of the medicine is clear. If it is not, use another syringe
• Make sure you know the amount to be injected
• Check the area of your stomach where you will inject to see if the last injection caused redness, change in skin color, swelling, discharge, or pain that still persists. If this happens, consult your doctor or nurse

I

To reduce pain and bruising at the injection site, it is necessary to use the syringes correctly. Follow the instructions carefully.

Instructions for syringe without safety system

• Preparation of the injection site:

Before giving the injection, wash and dry your hands. With a cotton swab, clean (without rubbing) the area you have chosen for the injection.

Choose a different area of your stomach for each injection.

• Remove the cap that protects the needle.

You may see a drop at the end of the needle. If this happens, remove the drop by gently tapping the body of the syringe (with the needle pointing down).

• Administration of the injection:

The pre-filled syringe is ready for immediate use. Choose an area on the right or left side of your stomach. It should be at least 5 cm away from your navel and towards the sides. Hold the syringe so that the needle points down (vertically at a 90-degree angle), within the thickness of a skin fold that you are pinching with your thumb and index finger. The skin fold should be kept pinched throughout the injection.

• Dispose of the syringe immediately in the appropriate container.

The disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.

Instructions for syringe with safety system

• Preparation of the injection site:

Before giving the injection, wash and dry your hands. With a cotton swab, clean (without rubbing) the area you have chosen for the injection.

Choose a different area of your stomach for each injection.

• First, tilt the trap to one side by about 90 degrees. Important: Do not remove the cap before tilting the trap!

• Remove the cap that protects the needle.

You may see a drop at the end of the needle. If this happens, remove the drop by gently tapping the body of the syringe (with the needle pointing down).

• Administration of the injection:

The pre-filled syringe is ready for immediate use. Choose an area on the right or left side of your stomach. It should be at least 5 cm away from your navel and towards the sides. Hold the syringe so that the needle points down (vertically at a 90-degree angle), within the thickness of a skin fold that you are pinching with your thumb and index finger. The skin fold should be kept pinched throughout the injection.

• Secure the needle:

Fix the needle by placing the trap against a hard and stable surface using one hand. Then press the trap down. Important: Do not use your finger to fix the needle to the trap! Tilt the trap until the needle is inserted into the plastic piece, making a clicking sound.

When you have finished

1. To avoid bruising, do not rub the injection site after the injection has been given.
2. Put the used syringe in the container for sharp objects. Close the container lid tightly and keep it out of the reach of children. When the container is full, dispose of it as your doctor or pharmacist has instructed.

The disposal of unused medicine and all materials that have come into contact with it will be carried out in accordance with local regulations.

C

• Switching from Enoxaparina Ledraxen to medications that reduce blood coagulation called vitamin K antagonists (e.g., warfarin)

Your doctor will request a blood test to determine a parameter called INR and will tell you when to stop treatment with Enoxaparina Ledraxen.

• Switching from medications that reduce blood coagulation called vitamin K antagonists (e.g., warfarin) to Enoxaparina Ledraxen

Stop using the vitamin K antagonist. Your doctor will request a blood test to determine a parameter called INR and will tell you when to start using Enoxaparina Ledraxen.

• Switching from Enoxaparina Ledraxen to treatment with direct oral anticoagulants

Stop using Enoxaparina Ledraxen. Start taking the direct oral anticoagulant 0-2 hours before the next scheduled injection, and then continue as usual.

• Switching from treatment with direct oral anticoagulant to Enoxaparina Ledraxen

Stop taking the direct oral anticoagulant. Do not start treatment with Enoxaparina Ledraxen until 12 hours have passed since the last dose of the direct oral anticoagulant.

If you use more Enoxaparina Ledraxen than you should

If you think you have used too much or too little Enoxaparina Ledraxen, inform your doctor, nurse, or pharmacist immediately, even if you do not have any signs of problems. If a child accidentally injects or swallows Enoxaparina Ledraxen, take them to the emergency department of a hospital immediately.

S

If you forget to administer a dose, do so as soon as you remember. Do not use a double dose on the same day to make up for forgotten doses. To ensure you do not forget any doses, using a diary may be helpful.

S

It is essential that you continue to receive Enoxaparina Ledraxen until your doctor decides to stop treatment. If you stop using it, a blood clot may form, which can be very dangerous.

If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Severe side effects

Stop treatment with Enoxaparina Ledraxen and inform your doctor or nurse immediately if you experience any signs of a severe allergic reaction (such as a rash, breathing or swallowing problems, swelling of the face, lips, tongue, mouth, throat, or eyes).

Stop treatment with Enoxaparina Ledraxen and inform your doctor or nurse immediately if you experience any of the following symptoms:

• a widespread, red, and scaly rash with bumps under the skin and blisters, accompanied by fever. Symptoms usually appear at the start of treatment (acute generalized exanthematous pustulosis).

Like other similar medications for reducing blood clots, Enoxaparina Ledraxen may cause bleeding. This could be life-threatening. In some cases, the bleeding may not be apparent.

Inform your doctor immediately if:

• you have any bleeding that does not stop by itself
• you have signs of excessive bleeding (such as feeling very weak, tired, pale, or dizzy with a headache or unexplained swelling).

Your doctor may decide to keep you under close observation or change your medication.

You must inform your doctor immediately:

• if you experience any signs of a blood vessel blockage due to a blood clot, such as:

• cramp-like pain, redness, warmth, or swelling in one of your legs – which are symptoms of deep vein thrombosis
• difficulty breathing, chest pain, fainting, or coughing up blood – which are symptoms of pulmonary embolism

• if you have a painful skin rash with dark red spots under the skin that do not disappear when pressed.

Your doctor may request a blood test to check the platelet count.

O

Very common (may affect more than 1 in 10 people)

• Bleeding.
• Increased liver enzymes.

Common (may affect up to 1 in 10 people)

• If bruises appear more frequently than usual. This could be due to a blood problem caused by a low platelet count.
• Pink patches on the skin. These appear more frequently in the area where Enoxaparina Ledraxen was injected.
• Skin rash (hives, urticaria).
• Redness and itching of the skin.
• Bruising or pain at the injection site.
• Decrease in the number of red blood cells in the blood.
• Increase in the number of platelets in the blood.
• Headache.

Uncommon (may affect up to 1 in 100 people)

• Sudden severe headache. This could be a sign of bleeding in the brain.
• Sensation of tenderness and swelling of the stomach. This could be indicative of gastric bleeding.
• Large, irregular red lesions on the skin, with or without blisters.
• Skin irritation (local irritation).
• You may notice yellowing of the skin or eyes, and darkening of the urine color. This could be due to a liver problem.

Rare (may affect up to 1 in 1,000 people)

• Severe allergic reaction. The signs of this reaction may include: skin rash, swallowing or breathing problems, swelling of the lips, face, throat, or tongue.
• Increased potassium in the blood. This is more likely to occur in people with kidney problems or diabetes. Your doctor can check this with a blood test.
• Increased number of eosinophils in the blood. Your doctor can check this with a blood test.
• Hair loss.
• Osteoporosis (a disease in which bones can fracture more easily)

after prolonged use.

• Numbness, tingling, and weakness in the muscles (especially in the lower body) when a lumbar puncture or spinal anesthesia has been performed.
• Loss of bladder or bowel control (so you cannot control your needs).
• Hardening or nodule at the injection site.

C

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of Enoxaparina Ledraxen

Store below 25 °C.

Do not freeze.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date stated on the packaging after CAD. The expiration date is the last day of the month indicated.

Do not use this medication if you notice any visible change in the appearance of the solution.

Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medications at the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medications. This will help protect the environment.

6. Package contents and additional information

Composition of Enoxaparina Ledraxen

• The active ingredient is enoxaparin sodium.

Each 0.2 ml pre-filled syringe contains an anti-Xa activity of 2,000 IU (equivalent to 20 mg) of enoxaparin sodium

• The other components are water for injectable preparations.

Appearance of the product and package contents

The liquid is transparent, colorless, or light yellow.

0.2 ml of solution contained in a transparent, neutral, type I glass syringe with a fixed needle and a closed needle protector with a chlorobutyl rubber stopper and a black polypropylene plunger (without an automatic safety system).

Packages of 1, 2, 6, 10, 20, or 50 pre-filled syringes.

For 0.2 ml and 0.4 ml syringes, the syringes are not graduated.

For 0.6 ml, 0.8 ml, and 1 ml syringes, the syringes are graduated.

Only some package sizes may be marketed.

Marketing authorization holder

Venipharm

4, Bureaux de la Colline

92210 Saint-Cloud

FRANCE

+33 1 47 71 16 98

[email protected]

Manufacturer

Centre Spécialités Pharmaceutiques (France)

ZAC des Suzots

35 rue de la Chapelle F-63450

Saint-Amant Tallende,

FRANCE

This medication is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:

Germany Enoxaparin Ledraxen

United Kingdom Ledraxen

Sweden: Enoxaparin Ledraxen

Spain: Enoxaparina Ledraxen

France: Enoxaparine Arrow

Latvia: Enoxaparin sodium Ledraxen

Lettonia Enoxaparin sodium Ledraxen

Austria: Enoxaparin Ledraxen

Cyprus: Ledraxen

Czech Republic: Enoxaparin sodium Ledraxen

Estonia: Enoxaparin sodium Ledraxen

Finland: Enoxaparin Ledraxen

Croatia: Enoksaparinnatrij Ledraxen

Ireland: Enoxaparin sodium Ledraxen

Norway Enoxaparin Ledraxen

Poland: Enoxaparin sodium Ledraxen

Portugal: Enoxaparin Ledraxen

Slovakia: Ledraxen

Slovenia: Enoksaparin Ledraxen

Date of the last revision of this leaflet:June 2023

Other sources of information

Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)